医学
内科学
心力衰竭
癌症
心房颤动
危险系数
回顾性队列研究
心肌病
队列
置信区间
作者
Vennela Avula,Garima Sharma,Mikhail Kosiborod,Muthiah Vaduganathan,Tomas G. Neilan,Teresa López‐Fernández,Susan Dent,Lauren A. Baldassarre,Marielle Scherrer‐Crosbie,Ana Barac,Jennifer Liu,Anita Deswal,Sumanth Khadke,En‐Hua Yang,Bonnie Ky,Daniel J. Lenihan,Anju Nohria,Sourbha S. Dani,Sarju Ganatra
标识
DOI:10.1016/j.jchf.2023.08.026
摘要
Certain antineoplastic therapies are associated with an increased risk of cardiomyopathy and heart failure (HF). Sodium glucose co-transporter 2 (SGLT2) inhibitors improve outcomes in patients with HF.
科研通智能强力驱动
Strongly Powered by AbleSci AI